Therapeutic agent for chronic obstructive pulmonary disease and method of treatment for chronic obstructive pulmonary disease with the same

Details for Australian Patent Application No. 2004261527 (hide)

Owner Activus Pharma Co., Ltd

Inventors Aoki, Yasuo; Takagaki, Hidetsugu; Mizutani, Nobuaki; Ishiwara, Mitsuteru

Agent FB Rice

Pub. Number AU-B-2004261527

PCT Pub. Number WO2005/012251

Priority 2003-203699 30.07.03 JP

Filing date 27 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 23 September 2010

International Classifications

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 215/38 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/012251 Priority application(s): WO2005/012251

4 October 2007 Assignment before Grant

  Dainippon Ink and Chemicals, Inc. The application has been assigned to Activus Pharma Co., Ltd

23 September 2010 Application Accepted

  Published as AU-B-2004261527

11 November 2010 Assignment before Grant

  Activus Pharma Co., Ltd The application has been assigned to Mariposa Health Limited

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261534-Benzylamine derivative

2004261522-Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food